GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Eaton Vance Enhanced Equity Income Fund II (NYSE:EOS) » Definitions » Enterprise Value

Eaton Vance Enhanced Equityome Fund II (Eaton Vance Enhanced Equityome Fund II) Enterprise Value : $1,092.1 Mil (As of May. 26, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Eaton Vance Enhanced Equityome Fund II Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. This ratio does not apply to banks.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. This ratio does not apply to banks.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Eaton Vance Enhanced Equityome Fund II's Enterprise Value is $1,092.1 Mil. Eaton Vance Enhanced Equityome Fund II's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $280.4 Mil. Therefore, Eaton Vance Enhanced Equityome Fund II's EV-to-Revenue ratio for today is 3.90.


Eaton Vance Enhanced Equityome Fund II Enterprise Value Historical Data

The historical data trend for Eaton Vance Enhanced Equityome Fund II's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eaton Vance Enhanced Equityome Fund II Enterprise Value Chart

Eaton Vance Enhanced Equityome Fund II Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial 874.09 1,079.85 1,256.59 861.83 979.16

Eaton Vance Enhanced Equityome Fund II Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,256.59 832.38 861.83 935.75 979.16

Competitive Comparison of Eaton Vance Enhanced Equityome Fund II's Enterprise Value

For the Asset Management subindustry, Eaton Vance Enhanced Equityome Fund II's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eaton Vance Enhanced Equityome Fund II's Enterprise Value Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Eaton Vance Enhanced Equityome Fund II's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Eaton Vance Enhanced Equityome Fund II's Enterprise Value falls into.



Eaton Vance Enhanced Equityome Fund II Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Eaton Vance Enhanced Equityome Fund II's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Eaton Vance Enhanced Equityome Fund II's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eaton Vance Enhanced Equityome Fund II  (NYSE:EOS) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Eaton Vance Enhanced Equityome Fund II's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1092.147/280.366
=3.90

Eaton Vance Enhanced Equityome Fund II's current Enterprise Value is $1,092.1 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Eaton Vance Enhanced Equityome Fund II's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $280.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eaton Vance Enhanced Equityome Fund II Enterprise Value Related Terms

Thank you for viewing the detailed overview of Eaton Vance Enhanced Equityome Fund II's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Eaton Vance Enhanced Equityome Fund II (Eaton Vance Enhanced Equityome Fund II) Business Description

Traded in Other Exchanges
N/A
Address
Two International Place, Suite 1400, Boston, MA, USA, 02110
Eaton Vance Enhanced Equity Income Fund II is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income, with a secondary objective of capital appreciation. It invests in a portfolio of large and mid-cap securities in the sectors such as Information Technology, Consumer Discretionary, Communication Services, Healthcare, Industrials, Consumer Staples, Financials, Materials, and Energy.
Executives
Anchal Pachnanda officer: Officer TWO INTERNATIONAL PLACE, BOSTON MA 02110
Williams Ray Kelly Jr officer: President TWO INTERNATIONAL PLACE, BOSTON MA 02110
Alan C. Bowser other: Trustee TWO INTERNATIONAL PLACE, BOSTON MA 02110
Nicholas Dilorenzo officer: Secretary TWO INTERNATIONAL PLACE, BOSTON MA 02110
Nancy A Wiser other: Trustee WELLS FARGO FUNDS MANAGEMENT, 200 BERKELEY STREET, 19TH FLOOR, BOSTON MA 02116
Jill Damon officer: Secretary TWO INTERNATIONAL PLACE, BOSTON MA 02110
Douglas R Rogers other: Portfolio Manager TWO INTERNATIONAL PLACE, BOSTON MA 02110
Kimberly M Roessiger officer: Secretary TWO INTERNATIONAL PLACE, BOSTON MA 02110
Deidre E Walsh officer: Vice President TWO INTERNATIONAL PLACE, BOSTON MA 02110
Keith Quinton other: Trustee TWO INTERNATIONAL PLACE, BOSTON MA 02110
Marcus L. Smith other: Trustee 555 17TH STREET, SUITE 3700, DCT INDUSTRIAL TRUST INC., DENVER CO 80202
Froio Richard F Sr officer: [email protected] C/O BISYS FUND SERVICES, 60 STATE ST., BOSTON MA 02129
Mark R Fetting other: Trustee LEGG MASON, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Scott E Wennerholm other: Trustee TWO INTERNATIONAL PLACE, BOSTON MA 02110
Yana S Barton other: Portfolio Manager TWO INTERNATIONAL PLACE, BOSTON MA 02110

Eaton Vance Enhanced Equityome Fund II (Eaton Vance Enhanced Equityome Fund II) Headlines